MarketWatch

BrainScope's EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

The MarketWatch News Department was not involved in the creation of this content. Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's ...
Business Wire

BrainScope Completes Proof-of-Concept for Groundbreaking Early Alzheimer’s Prediction Biomarker

ROCKVILLE, Md.--(BUSINESS WIRE)--BrainScope, a leader in brain diagnostics, today announced the successful completion of the proof-of-concept phase for a novel brain activity-based biomarker for the ...
Nasdaq

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203

– Demonstrated target engagement and response prediction for ALTO-203 by theta/beta ratio, a commonly used EEG index of cortical arousal and attentional control – – ALTO-203, a non-stimulant compound ...
Nasdaq

Alto Neuroscience Announces Robust Replication of EEG Biomarker to Objectively Identify Patients with Cognitive Impairment in Schizophrenia

– Independent prospective analysis validates theta-band inter-trial coherence (ITC) as an important, objective measure to distinguish patients with schizophrenia from healthy individuals – – A ...
Business Wire

BrainScope’s EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

ROCKVILLE, Md.--(BUSINESS WIRE)--BrainScope, a commercial-stage medical neurotechnology company applying artificial intelligence and computational neuroscience to brain electrical activity (EEG), ...
MarketWatch

CORRECTING AND REPLACING:BrainScope's EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

The MarketWatch News Department was not involved in the creation of this content. Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's ...
Morningstar

BrainScope’s EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope’s strategic focus on early, actionable dementia detection. BrainScope, a commercial ...